ROCKVILLE, Md., March 4, 2011 /PRNewswire/ — Ariadne,
a leader in bioinformatics software and knowledge integration,
announced that National Cancer Institute (NCI) has renewed their
license for Pathway
Studio® Enterprise system that includes the ResNet®
Mammalian database and Ariadne MedScan® text processing
technology for site-wide use. Pathway Studio offers researchers the
ability to create new cancer disease pathways and develop
mechanistic rationale for disease based on molecular facts from
public data and the latest research findings recovered using
MedScan®. In addition, Pathway Studio supports
interdepartmental and institutional data sharing and integration of
research findings as well as experimental data to augment the
understanding of the molecular basis of cancer.
“We are proud for the opportunity to work with leaders in cancer
research like those at NCI, the Roswell Park Cancer Institute, MD
Anderson, Georgetown University, and contribute to the state of
knowledge in oncology. Our tools can be productive when used
individually, but can also help researchers to work
collaboratively, to share findings between research institutes,”
states Dr. Ilya Mazo, President, Ariadne. He continues,
“Researchers have access to a wide-range of information, yet
extracting actionable knowledge or intelligence from this data can
often prove difficult. We welcome the opportunity to help NCI
researchers capture, curate and dispense our bioinformatics
expertise in support of their scientific innovation.”
Pathway Studio’s workflow approach allows researchers to mine,
integrate, analyze and visualize results individually or as an
integrated workflow. Each step can be saved, then updated or
modified as new information becomes available. Separate a
‘/>”/>
